# Using Amniotic Membrane as the Carrier for ex Vivo Cell Culture for Cell Therapy in Ocular Surface Reconstruction

> **NCT01341223** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Human Amniotic Membrane(AM)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01341223
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2016-03
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2012-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341223, "Using Amniotic Membrane as the Carrier for ex Vivo Cell Culture for Cell Therapy in Ocular Surface Reconstruction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01341223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*